Ida Netterberg

Risk Factors for Development of Cholestatic Drug-Induced Liver Injury: Inhibition of Hepatic Basolateral Bile Acid Transporters Multidrug Resistance-Associated Proteins 3 and 4

Kathleen Köck, Brian C. Ferslew, Ida Netterberg et al. · Drug Metabolism and Disposition · 2013 · 156 citations · Full text

Medicine, Biochemistry, Pharmacology +16

A<scp>PK/PD</scp>Analysis of Circulating Biomarkers and Their Relationship to Tumor Response in Atezolizumab‐Treated non‐small Cell Lung Cancer Patients

Ida Netterberg, Chi‐Chung Li, Luciana Molinero et al. · Clinical Pharmacology & Therapeutics · 2018 · 38 citations · Full text

Medicine, Oncology, Pharmacology +17

Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoring

Ida Netterberg, Elisabet I. Nielsen, Lena E. Friberg et al. · Cancer Chemotherapy and Pharmacology · 2017 · 27 citations · Full text

Medicine, Hematology, Immunology +12

The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin‐6 and C‐reactive protein by modelling

Ida Netterberg, Mats O. Karlsson, Elisabet I. Nielsen et al. · British Journal of Clinical Pharmacology · 2017 · 16 citations · Full text

Medicine, Immunology, Oncology +13

Comparing Circulating Tumor Cell Counts with Dynamic Tumor Size Changes as Predictor of Overall Survival: A Quantitative Modeling Framework

Ida Netterberg, Mats O. Karlsson, Leon W.M.M. Terstappen et al. · Clinical Cancer Research · 2020 · 13 citations · Full text

Medicine, Oncology, Pharmacology +14